When does a fingerprint constitute a diagnostic?

Lancet

Volumn 368, Issue 9540, 2006, Pages 971-973

  White, Melanie Y ^a   Gundry, Rebekah L ^a   Cordwell, Stuart J ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE; PLASMA PROTEIN; PROTEIN; PROTEOME; SERUM AMYLOID A;

ARTICLE; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE MARKER; HUMAN; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEOMICS; SAMPLING; SCREENING; SENSITIVITY ANALYSIS; SEROLOGY; SPUTUM ANALYSIS; STATISTICAL ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONISATION TIME OF FLIGHT; TUBERCULOSIS; VALIDATION STUDY;

EID: 33748463168     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69379-3     Document Type: Note

References (11)

1. Agranoff D., Fernandez-Reyes D., Papadopoulos M., et al. Identification of diagnostic markers for tuberculosis by serum proteomic fingerprinting. Lancet (2006). published online Sept 14. DOI:10.1016/S0140-6736(06)69342-2
2. Hortin G. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 52 (2006) 1223-1237
3. Liotta L., and Petricoin E. Serum peptidome for cancer detection: spinning biological trash into diagnostic gold. J Clin Invest 116 (2006) 26-30
4. Koomen J., Li D., Xiao L., et al. Direct tandem mass spectrometry reveals limitations protein profiling experiments for plasma biomarker discovery. J Proteome Res 4 (2005) 972-981
5. Petricoin E., Ardekani A., Hitt V., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
6. Plebani M. Proteomics: the next revolution in laboratory medicine?. Clin Chim Acta 357 (2005) 113-122
7. Omenn G., States D., Adamski M., et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5 (2005) 3226-3245
8. Seibert V., Wiesner A., Buschmann T., and Meuer J. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) and ProteinChip technology in proteomics research. Pathol Res Pract 200 (2004) 83-94
9. Barker P., Wagner P., Stein S., Bunk D., Srivastava S., and Omenn G. Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology-national cancer institute standards, methods, assays, reagents and technologies workshop, August 18-19, 2005. Clin Chem 52 (2006) 1669-1674
10. Haab B., Geierstanger B., Michailidis G., et al. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics 5 (2005) 3278-3291
11. Rai A., Gelfand C., Haywood B., et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5 (2005) 3263-3277